Unintended consequences of decreased PSA-based prostate cancer screening

被引：0
|
作者：
Thomas Ahlering
Linda My Huynh
Kamaljot S. Kaler
Stephen Williams
Kathryn Osann
Jean Joseph
David Lee
John W. Davis
Ronney Abaza
Jihad Kaouk
Vipul Patel
Isaac Yi Kim
James Porter
Jim C. Hu
机构：
[1] University of California,Department of Urology
[2] Irvine Health,Division of Urology, Department of Surgery
[3] University of Texas Medical Branch at Galveston,Division of Hematology
[4] University of California,Oncology, Department of Medicine
[5] Irvine,Department of Urology
[6] University of Rochester,Perelman School of Medicine
[7] University of Pennsylvania,Department of Urology
[8] UT MD Anderson Cancer Center,Department of Urology
[9] Ohio Health Robotic Urologic Surgeons,Department of Urology
[10] Cleveland Clinic,Department of Urology
[11] Florida Celebration Health,Department of Urology
[12] Rutgers Cancer Center of New Jersey,undefined
[13] Swedish Medical Center,undefined
[14] Weill Cornell Medicine,undefined
来源：
World Journal of Urology | 2019年 / 37卷
关键词：
Prostate cancer; Screening; USPSTF recommendation; High risk;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：489 / 496
页数：7
相关论文
共 50 条
  • [1] Unintended consequences of decreased PSA-based prostate cancer screening
    Ahlering, Thomas
    Huynh, Linda My
    Kaler, Kamaljot S.
    Williams, Stephen
    Osann, Kathryn
    Joseph, Jean
    Lee, David
    Davis, John W.
    Abaza, Ronney
    Kaouk, Jihad
    Patel, Vipul
    Kim, Isaac Yi
    Porter, James
    Hu, Jim C.
    [J]. WORLD JOURNAL OF UROLOGY, 2019, 37 (03) : 489 - 496
  • [2] UNINTENDED CONSEQUENCES OF DECREASED PSA-BASED PROSTATE CANCER SCREENING
    Ahlering, Thomas
    Huynh, Linda
    Kamaljot, Kaler
    Williams, Stephen
    Osann, Kathryn
    Joseph, Jean
    Lee, David
    Davis, John
    Abaza, Ronney
    Kaouk, Jihad
    Patel, Vipul
    Kim, Isaac
    Porter, James
    Hu, Jim
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E1108 - E1109
  • [3] Correction to: Unintended consequences of decreased PSA-based prostate cancer screening
    Thomas Ahlering
    Linda My Huynh
    Kamaljot S. Kaler
    Stephen Williams
    Kathryn Osann
    Jean Joseph
    David Lee
    John W. Davis
    Ronney Abaza
    Jihad Kaouk
    Vipul Patel
    Isaac Yi Kim
    James Porter
    Jim C. Hu
    [J]. World Journal of Urology, 2020, 38 : 807 - 807
  • [4] Unintended consequences of decreased PSA-based prostate cancer screening (vol 37, pg 489, 2019)
    Ahlering, Thomas
    Huynh, Linda My
    Kaler, Kamaljot S.
    Williams, Stephen
    Osann, Kathryn
    Joseph, Jean
    Lee, David
    Davis, John W.
    Abaza, Ronney
    Kaouk, Jihad
    Patel, Vipul
    Kim, Isaac Yi
    Porter, James
    Hu, Jim C.
    [J]. WORLD JOURNAL OF UROLOGY, 2020, 38 (03) : 807 - 807
  • [5] PSA-based screening for prostate cancer
    Byrne, Derek
    [J]. TRENDS IN UROLOGY & MENS HEALTH, 2013, 4 (01) : 12 - 12
  • [6] Prostate cancer: Honing in on the true value of PSA-based screening
    Farley S.J.
    [J]. Nature Reviews Urology, 2009, 6 (11) : 573 - 573
  • [7] PSA-based screening for prostate cancer after renal transplantation
    Malavaud, B
    Hoff, M
    Miédouge, M
    Rostaing, L
    [J]. TRANSPLANTATION, 2000, 69 (11) : 2461 - 2462
  • [8] Moving beyond negative campaign for PSA-based screening for prostate cancer
    Ito, Kazuto
    Sekine, Yoshitaka
    Suzuki, Kazuhiro
    Kurosawa, Isao
    [J]. CANCER SCIENCE, 2023, 114 : 1536 - 1536
  • [9] Introduction to a seminar on revisiting the value of PSA-based prostate cancer screening
    Carlsson, Sigrid, V
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 76 - 77
  • [10] PSA-based screening for prostate cancer: How does it compare with other cancer screening tests?
    Crawford, E. David
    Abrahamsson, Per-Anders
    [J]. EUROPEAN UROLOGY, 2008, 54 (02) : 262 - 273
12345